SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $197,595 | -51.1% | 223,019 | -13.3% | 0.00% | – |
| Q3 2022 | $404,000 | +29.1% | 257,319 | +65.1% | 0.00% | – |
| Q2 2022 | $313,000 | -19.5% | 155,819 | -6.6% | 0.00% | – |
| Q1 2022 | $389,000 | -53.5% | 166,825 | -7.2% | 0.00% | -100.0% |
| Q4 2021 | $836,000 | -27.8% | 179,757 | +18.5% | 0.00% | 0.0% |
| Q3 2021 | $1,158,000 | +6.2% | 151,757 | +34.9% | 0.00% | 0.0% |
| Q2 2021 | $1,090,000 | +52.9% | 112,457 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $713,000 | -4.7% | 86,271 | -21.3% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | -43.1% | 109,635 | -6.9% | 0.00% | -50.0% |
| Q3 2020 | $1,314,000 | -9.8% | 117,820 | -49.2% | 0.00% | 0.0% |
| Q2 2020 | $1,456,000 | +6833.3% | 231,829 | +1960.7% | 0.00% | – |
| Q1 2020 | $21,000 | -75.6% | 11,250 | -29.7% | 0.00% | – |
| Q1 2016 | $86,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |